RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 Agomelatine Demonstrates Broad Efficacy in Depression
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 2
SP 15
OP 16
DO 10.1177/155989770700700208
UL http://mdc.sagepub.com/content/7/2/15.abstract
AB Agomelatine, a melatonergic agonist and a selective 5-HT2c antagonist, is a novel antidepressant in development for major depressive disorder. This article discusses a meta-analysis of pooled data from three clinical studies. The objective of the meta-analysis was to determine whether gender or baseline severity of depression had any influence on agomelatine efficacy.